Role of RNA splicing in mediating lineage-specific expression of the Von Willebrand factor gene in the endothelium

Blood

Volumn 121, Issue 21, 2013, Pages 4404-4412

  Yuan, Lei ^a   Janes, Lauren ^a   Beeler, David ^a   Spokes, Katherine C ^a   Smith, Joshua ^a   Li, Dan ^a   Jaminet, Shou Ching ^a   Oettgen, Peter ^a   Aird, William C ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; BLOOD CLOTTING FACTOR 10; COMPLEMENTARY DNA; DOWN SYNDROME CRITICAL REGION 1 PROTEIN; HEMOGLOBIN BETA CHAIN; LUCIFERASE; MESSENGER RNA; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL FRACTIONATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; ENHANCER REGION; EXON; GENE FUNCTION; GENE TARGETING; GENETIC TRANSFECTION; HAGFISH; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO GENE TRANSFER; IN VITRO STUDY; INTRON; MEGAKARYOCYTE; MOUSE; NONHUMAN; NUCLEAR EXPORT; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN STABILITY; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; TRANSIENT TRANSFECTION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; ANIMAL; CATTLE; CELL LINEAGE; GENETICS; HEMOSTASIS; LACTOSE OPERON; PHYSIOLOGY; SPECIES DIFFERENCE; VASCULAR ENDOTHELIUM;

ANIMALS; CATTLE; CELL LINEAGE; ENDOTHELIUM, VASCULAR; EXONS; GENE KNOCK-IN TECHNIQUES; HEMOSTASIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTRONS; LAC OPERON; MICE; PROMOTER REGIONS, GENETIC; RNA SPLICING; SPECIES SPECIFICITY; VON WILLEBRAND FACTOR;

MLCS; MLOWN;

EID: 84880422849     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-12-473785     Document Type: Article

References (55)

1. Ruggeri ZM. The role of von Willebrand factor in thrombus formation. Thromb Res. 2007; 120(Suppl 1):S5-S9.
2. Aird WC. Vascular bed-specific hemostasis: role of endothelium in sepsis pathogenesis. Crit Care Med. 2001;29(7 Suppl):S28-S34, discussion S34-S35.
3. Yamamoto K, de Waard V, Fearns C, Loskutoff DJ. Tissue distribution and regulation of murine von Willebrand factor gene expression in vivo. Blood. 1998;92(8): 2791-2801.
4. Patel KN, Soubra SH, Bellera RV, Dong JF, McMullen CA, Burns AR, Rumbaut RE. Differential role of von Willebrand factor and P-selectin on microvascular thrombosis in endotoxemia. Arterioscler Thromb Vasc Biol. 2008;28(12):2225-2230.
5. Senis YA, Richardson M, Tinlin S, Maurice DH, Giles AR. Changes in the pattern of distribution of von Willebrand factor in rat aortic endothelial cells following thrombin generation in vivo. Br J Haematol. 1996;93(1):195-203.
6. Guan J, Guillot PV, Aird WC. Characterization of the mouse von Willebrand factor promoter. Blood. 1999;94(10):3405-3412.
7. Janel N, Schwachtgen JL, Bakhshi MR, Barek L, Meyer D, Kerbiriou-Nabias D. Comparison of the 59-flanking sequences of the human and bovine von Willebrand factor-encoding genes reveals alternation of highly homologous domains with species-specific Alu-type repeats. Gene. 1995; 167(1-2):291-295.
8. Mancuso DJ, Tuley EA, Westfield LA, et al. Structure of the gene for human von Willebrand factor. J Biol Chem. 1989;264(33): 19514-19527.
9. Minami T, Donovan DJ, Tsai JC, Rosenberg RD, Aird WC. Differential regulation of the von Willebrand factor and Flt-1 promoters in the endothelium of hypoxanthine phosphoribosyltransferase-targeted mice. Blood. 2002;100(12):4019-4025.
10. Liu J, Yuan L, Molema G, et al. Vascular bed-specific regulation of the von Willebrand factor promoter in the heart and skeletal muscle. Blood. 2011;117(1):342-351.
11. Yuan L, Nikolova-Krstevski V, Zhan Y, et al. Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene. Circ Res. 2009;104(9):1049-1057.
12. Liu J, Kanki Y, Okada Y, et al. A 1220 GATA motif mediates basal but not endotoxin-repressible expression of the von Willebrand factor promoter in Hprt-targeted transgenic mice. J Thromb Haemost. 2009;7(8):1384-1392.
13. Nott A, Meislin SH, Moore MJ. A quantitative analysis of intron effects on mammalian gene expression. RNA. 2003;9(5):607-617.
14. Bradnam KR, Korf I. Longer first introns are a general property of eukaryotic gene structure. PLoS ONE. 2008;3(8):e3093.
15. Wiegand HL, Lu S, Cullen BR. Exon junction complexes mediate the enhancing effect of splicing on mRNA expression. Proc Natl Acad Sci USA. 2003;100(20):11327-11332.
16. Valencia P, Dias AP, Reed R. Splicing promotes rapid and efficient mRNA export in mammalian cells. Proc Natl Acad Sci USA. 2008;105(9): 3386-3391.
17. Jonsson JJ, Foresman MD, Wilson N, McIvor RS. Intron requirement for expression of the human purine nucleoside phosphorylase gene. Nucleic Acids Res. 1992;20(12):3191-3198.
18. Buchman AR, Berg P. Comparison of intron-dependent and intron-independent gene expression. Mol Cell Biol. 1988;8(10): 4395-4405.
19. Palmiter RD, Sandgren EP, Avarbock MR, Allen DD, Brinster RL. Heterologous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci USA. 1991;88(2): 478-482.
20. Choi T, Huang M, Gorman C, Jaenisch R. A generic intron increases gene expression in transgenic mice. Mol Cell Biol. 1991;11(6): 3070-3074.
21. Noé V, MacKenzie S, Ciudad CJ. An intron is required for dihydrofolate reductase protein stability. J Biol Chem. 2003;278(40): 38292-38300.
22. Deng TL, Li Y, Johnson LF. Thymidylate synthase gene expression is stimulated by some (but not all) introns. Nucleic Acids Res. 1989;17(2): 645-658.
23. Ryu WS, Mertz JE. Simian virus 40 late transcripts lacking excisable intervening sequences are defective in both stability in the nucleus and transport to the cytoplasm. J Virol. 1989;63(10):4386-4394.
24. Charron M, Chern JY, Wright WW. The cathepsin L first intron stimulates gene expression in rat sertoli cells. Biol Reprod. 2007;76(5): 813-824.
25. Juneau K, Miranda M, Hillenmeyer ME, Nislow C, Davis RW. Introns regulate RNA and protein abundance in yeast. Genetics. 2006;174(1): 511-518.
26. Furger A, O’Sullivan JM, Binnie A, Lee BA, Proudfoot NJ. Promoter proximal splice sites enhance transcription. Genes Dev. 2002;16(21): 2792-2799.
27. Moabbi AM, Agarwal N, El Kaderi B, Ansari A. Role for gene looping in intron-mediated enhancement of transcription. Proc Natl Acad Sci USA. 2012;109(22):8505-8510.
28. Bourdon V, Harvey A, Lonsdale DM. Introns and their positions affect the translational activity of mRNA in plant cells. EMBO Rep. 2001;2(5): 394-398.
29. Kappel A, Rönicke V, Damert A, Flamme I, Risau W, Breier G. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice. Blood. 1999; 93(12):4284-4292.
30. Schlaeger TM, Bartunkova S, Lawitts JA, Teichmann G, Risau W, Deutsch U, Sato TN. Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice. Proc Natl Acad Sci USA. 1997; 94(7):3058-3063.
31. Kleinschmidt AM, Nassiri M, Stitt MS, Wasserloos K, Watkins SC, Pitt BR, Jahroudi N. Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice. J Biol Chem. 2008; 283(5):2741-2750.
32. Khandekar M, Brandt W, Zhou Y, et al. A Gata2 intronic enhancer confers its pan-endothelia-specific regulation. Development. 2007;134(9): 1703-1712.
33. Pimanda JE, Chan WY, Wilson NK, et al. Endoglin expression in blood and endothelium is differentially regulated by modular assembly of the Ets/Gata hemangioblast code. Blood. 2008; 112(12):4512-4522.
34. Kwek KY, Murphy S, Furger A, et al. U1 snRNA associates with TFIIH and regulates transcriptional initiation. Nat Struct Biol. 2002; 9(11):800-805.
35. Rigo F, Martinson HG. Functional coupling of last-intron splicing and 39-end processing to transcription in vitro: the poly(A) signal couples to splicing before committing to cleavage. Mol Cell Biol. 2008;28(2):849-862.
36. Rose AB, Elfersi T, Parra G, Korf I. Promoter-proximal introns in Arabidopsis thaliana are enriched in dispersed signals that elevate gene expression. Plant Cell. 2008;20(3): 543-551.
37. Rosonina E, Ip JY, Calarco JA, et al. Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo. Mol Cell Biol. 2005;25(15):6734-6746.
38. Millevoi S, Decorsière A, Loulergue C, Iacovoni J, Bernat S, Antoniou M, Vagner S. A physical and functional link between splicing factors promotes pre-mRNA 39 end processing. Nucleic Acids Res. 2009;37(14): 4672-4683.
39. Proudfoot NJ, Furger A, Dye MJ. Integrating mRNA processing with transcription. Cell. 2002; 108(4):501-512.
40. Zhao C, Hamilton T. Introns regulate the rate of unstable mRNA decay. J Biol Chem. 2007; 282(28):20230-20237.
41. Luo MJ, Reed R. Splicing is required for rapid and efficient mRNA export in metazoans. Proc Natl Acad Sci USA. 1999;96(26):14937-14942.
42. Tokunaga K, Shibuya T, Ishihama Y, et al. Nucleocytoplasmic transport of fluorescent mRNA in living mammalian cells: nuclear mRNA export is coupled to ongoing gene transcription. Genes Cells. 2006;11(3):305-317.
43. Braddock M, Muckenthaler M, White MR, Thorburn AM, Sommerville J, Kingsman AJ, Kingsman SM. Intron-less RNA injected into the nucleus of Xenopus oocytes accesses a regulated translation control pathway. Nucleic Acids Res. 1994;22(24): 5255-5264.
44. Matsumoto K, Wassarman KM, Wolffe AP. Nuclear history of a pre-mRNA determines the translational activity of cytoplasmic mRNA. EMBO J. 1998;17(7):2107-2121.
45. Lu S, Cullen BR. Analysis of the stimulatory effect of splicing on mRNA production and utilization in mammalian cells. RNA. 2003;9(5):618-630.
46. Le Hir H, Izaurralde E, Maquat LE, Moore MJ. The spliceosome deposits multiple proteins 20-24 nucleotides upstream of mRNA exon-exon junctions. EMBO J. 2000;19(24):6860-6869.
47. Skoko N, Baralle M, Tisminetzky S, Buratti E. InTRONs in biotech. Mol Biotechnol. 2011;48(3): 290-297.
48. Nott A, Le Hir H, Moore MJ. Splicing enhances translation in mammalian cells: an additional function of the exon junction complex. Genes Dev. 2004;18(2):210-222.
49. Bouvet P, Wolffe AP. A role for transcription and FRGY2 in masking maternal mRNA within Xenopus oocytes. Cell. 1994;77(6):931-941.
50. Neuberger MS, Williams GT. The intron requirement for immunoglobulin gene expression is dependent upon the promoter. Nucleic Acids Res. 1988;16(14B):6713-6724.
51. Aird WC, Edelberg JM, Weiler-Guettler H, Simmons WW, Smith TW, Rosenberg RD. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol. 1997;138(5): 1117-1124.
52. Ruggeri ZM, Mannucci PM, Bader R, Barbui T. Factor VIII-related properties in platelets from patients with von Willebrand’s disease. J Lab Clin Med. 1978;91(1):132-140.
53. Weiss HJ, Pietu G, Rabinowitz R, Girma JP, Rogers J, Meyer D. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand’s disease. J Lab Clin Med. 1983;101(3): 411-425.
54. Mannucci PM, Lombardi R, Bader R, et al. Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor. Blood. 1985;66(4): 796-802.
55. McGrath RT, McRae E, Smith OP, O’Donnell JS. Platelet von Willebrand factor-structure, function and biological importance. Br J Haematol. 2010; 148(6):834-843.